Cydy sec filings

Author: qzmn

August undefined, 2024

WebApr 10, 2024 · A high-level overview of CytoDyn Inc. (CYDY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... SEC Filings. Type: All. WebCurrent report filing. 2. 04/25/22. D/A. Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4 (a) (5) under the Act. 6. 04/22/22.

SEC Filings :: CytoDyn Inc. (CYDY)

WebJul 27, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-K Annual report for the fiscal year ending Thursday, May 31, 2024 Home SEC Filings Cytodyn Inc. (CYDY) 10-K Annual Report Fri Jul 27 2024 10-K Annual Report Summary 10-K Annual Report 10-K YoY Changes Cytodyn Inc. CIK: 1175680 Ticker: CYDY GET DIRECTION ON YOUR INVESTMENTS WebApr 11, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-005291 Submitted to the SEC: Mon Apr 11 2024 5:19:33 PM … tryout day

CYDY CytoDyn Inc. SEC Filings MarketWatch

WebFind the latest CytoDyn Inc. (CYDY) stock quote, history, news and other vital information to help you with your stock trading and investing. WebFeb 28, 2024 · Fiscal Year Ended May 31, 2024. 10-K Filing. PDF HTML WebThe list of stock purchases and sales identified in the SEC filing [1] starts on 1/30/2024 and ends on 6/30/2024. During that period , Thomas Errico, M.D. sold 1,759,422 more shares than he bought, and Paul A. Rosenbaum sold 279,000 more shares than he bought. ... Lastly, I’m fervently hoping that CYDY includes two new replacement independent ... phillip ii of macedon coins

www.sec.gov

WebAug 31, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1933 … WebApr 10, 2024 · Latest SEC filings for CytoDyn Inc. (CYDY). If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. try out dongenWebApr 12, 2024 · CYDY CytoDyn Inc: Wall Street is to the SEC what Big Pharma is to the FDA, but on a tiny scale. Not a conspiracy, bu - #6560037 phillip ii accom

"WebJan 9, 2024 · Latest Quarterly or Annual Filing. 10-Q. January 9, 2024. Quarterly report pursuant to Section 13 or 15 (d) " - Cydy sec filings

Cydy sec filings

Web02/09/23. EFFECT. Notice of Effectiveness. 1. 02/03/23. POS AM. Post-effective amendment to a registration statement that is not immediately effective upon filing. WebNov 30, 2024 · QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1933 For the transition period from to Commission File Number: …

Did you know?

WebCYDY SEC Filings - CytoDyn Inc - Annual Report, Proxy Statement, Prospectus ... SEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor ... WebSEC gov • April 10, 2024 ... Actions Download. Exhibits EX-31.1 EX-31.2 EX-32 10-Q. Advertisement. Advertisement. Related Filings from CYDY. 8-K Current report filing. Mar 08, 2024. 8-K Current ...

WebCYDY CytoDyn Inc. SEC Filings MarketWatch Home Investing Quotes Stocks United States CYDY Finanicals Stock Screener Earnings Calendar Sectors CYDY U.S.: OTC … WebApr 10, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-Q Quarterly Report for the period ending Tuesday, February 28, 2024. ... Cytodyn Inc. (CYDY) 10-Q Quarterly Report Mon Apr 10 2024; SEC Filings. CYDY Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. CYDY Annual Reports. 10-K Annual …

WebSEC gov • April 10, 2024 ... Actions Download. Exhibits EX-31.1 EX-31.2 EX-32 10-Q. Advertisement. Advertisement. Related Filings from CYDY. 8-K Current report filing. … WebDec 7, 2024 · SEC gov • December 07, 2024 ... Download. Exhibits 8-K EX-10.1. Advertisement. Advertisement. Related Filings from CYDY. 10-Q Quarterly report pursuant to Section 13 or 15(d) Jan 09, 2024. 8-K ...

WebCytoDyn Inc. focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. The company was formerly known as RexRay Corporation. Formally known as: CytoDyn Inc. View SEC Filings from CYDY instead. Refresh Summary Table View recent insider …

WebApr 10, 2024 · table of contents united statessecurities and exchange commissionwashington, dc 20549form quarterly report under section 13 or 15(d) of the securities exchange act of 1934for the phillip ii was the king of what empireWebCYDY / CytoDyn Inc - SEC Filings, Annual Report, Proxy Statement EXTENDED Overview Owners Insiders Short Interest Filings Financials Dividends Earnings Forecast SEC … tryout edubrandWebCytoDyn Inc. focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 … tryout drills hockeyWebJan 10, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-000190 Submitted to the SEC: Mon Jan 10 2024 5:12:18 PM EST Accepted by the SEC: Mon Jan 10 2024 Period: Tuesday, November 30, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark … try out diet pillsWebOct 11, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-014943 Submitted to the SEC: Tue Oct 11 2024 5:21:45 PM EST Accepted by the SEC: Tue Oct 11 2024 Period: Wednesday, August 31, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media SEC.gov … phillip imaging centreWebNov 25, 2024 · FEATURED Music Licensing, Inc. (OTC:SONG) Announces Groundbreaking Research and Plans to Develop Proprietary AI Music Technology • Apr 10, 2024 8:30 AM. ILUS Files Its 2024 Annual Report With the SEC, Confirming a 595% Revenue Increase Over 2024 • ILUS • Apr 10, 2024 8:04 AM. M2Bio Appoints Ze-ev Krein as Chairman of … phillipi mansfield placeWebJul 2, 2024 · Since 2024, there have been 4 Schedule 13D forms (beneficial ownership report) filed for the company CytoDyn Inc. (stock symbol CYDY) by 3 beneficial owners. … try out edubrand